Hypothalamic orexin--a neurons are involved in the response of the brain stress system to morphine withdrawal
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Both the hypothalamus-pituitary-adrenal (HPA) axis and the extrahypothalamic brain stress system are key elements of the neural circuitry that regulates the negative states during abstinence from chronic drug exposure. Orexins have recently been hypothesized to modulate the extended amygdala and to contribute to the negative emotional state associated with dependence. This study examined the impact of chronic morphine and withdrawal on the lateral hypothalamic (LH) orexin A (OXA) gene expression and activity as well as OXA involvement in the brain stress response to morphine abstinence. Male Wistar rats received chronic morphine followed by naloxone to precipitate withdrawal. The selective OX1R antagonist SB334867 was used to examine whether orexins' activity is related to somatic symptoms of opiate withdrawal and alterations in HPA axis and extended amygdala in rats dependent on morphine. OXA mRNA was induced in the hypothalamus during morphine withdrawal, which was accompanied by activation of OXA neurons in the LH. Importantly, SB334867 attenuated the somatic symptoms of withdrawal, and reduced morphine withdrawal-induced c-Fos expression in the nucleus accumbens (NAc) shell, bed nucleus of stria terminalis, central amygdala and hypothalamic paraventricular nucleus, but did not modify the HPA axis activity. These results highlight a critical role of OXA signalling, via OX1R, in activation of brain stress system to morphine withdrawal and suggest that all orexinergic subpopulations in the lateral hypothalamic area contribute in this response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Chronic morphine and morphine withdrawal do not modify the number of OXA neurons in the DMH, PFA and LLH regions of the lateral hypothalamus. Placebo and morphine-dependent groups were sacrificed 120 min after saline or naloxone administration. (A) Schematic anatomic representation of LH subdivisions adapted from Paxinos and Watson stereotaxic atlas [42]. (B–E, E′) Representative photographs illustrating regional orexin A cell expression in the LH. (F) Mean ± SEM in the three regions of the LH. 3V, third ventricle; f, fornix. Scale bars, 200 μm (B–E) and 20 μm (E′).](https://figures.cochat.ai/paper-figures/44a2d42d433e44fa89fe03ce01581882/hypothalamic-orexin-a-neurons-are-involved-in-the-response-of-the-brain-stress-figure-3.jpg)






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Naloxone-precipitated morphine withdrawal in rats that were chronically treated with morphine increased Hcrt-1 gene expression and Hcrt neuron activation in the lateral hypothalamus, and an Hcrt-1 receptor antagonist attenuated the somatic expression of naloxone-precipitated morphine withdrawal (Laorden et al., 2012).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Laorden et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963 · cited 1×
“Placebo and morphine-dependent groups were sacrificed 120 min after saline or naloxone administration. (A) Schematic anatomic representation of LH subdivisions adapted from Paxinos and Watson stereotaxic atlas”
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,831
Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richardson, J. A., Kozlowski, G. P., Wilson, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80949-6 · Cited by 5,501
The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity
de Lecea, L., Kilduff, T. S., Peyron, C., Gao, X.-B., Foye, P. E., Danielson, P. E., Fukuhara, C., Battenberg, E. L. F., Gautvik, V. T., Bartlett, F. S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.322 · Cited by 3,878
Neurons containing hypocretin (orexin) project to multiple neuronal systems
Peyron, C., Tighe, D. K., van den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. G., & Kilduff, T. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09996.1998 · Cited by 3,466 · cited 14×
“Chronic morphine treatment and naloxone-precipitated morphine withdrawal do not modify the number of OXA neurons in the LH To evaluate if chronic morphine and naloxone-precipitated morphine withdrawal differentially affects the number of OXA neurons in the LH, the cell counts of OXA immunoreactive profiles were taken…”
BackgroundResultInfluentialNarcolepsy in orexin Knockout Mice
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095 · cited 10×
“Chronic morphine treatment and naloxone-precipitated morphine withdrawal do not modify the number of OXA neurons in the LH To evaluate if chronic morphine and naloxone-precipitated morphine withdrawal differentially affects the number of OXA neurons in the LH, the cell counts of OXA immunoreactive profiles were taken…”
BackgroundInfluentialAddiction and the brain antireward system
Koob, G. F., & Le Moal, M. (2008) · Annual Review of Psychology · doi:10.1146/annurev.psych.59.103006.093548 · Cited by 1,457 · cited 4×
“Both the HPA axis and the extended amygdala are dysregulated by chronic administration of drugs of abuse [10,19,20].”
BackgroundInfluentialPhysiology and pharmacology of corticotropin-releasing factor.
Owens, M. J., & Nemeroff, C. B. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06673-6 · Cited by 1,142 · cited 1×
“CRF is widely distributed throughout the brain and plays a major role in coordinating the behavioral and autonomic responses to stress [7].”
BackgroundSawchenko, P. E., & Swanson, L. W. (1982) · Brain Research Reviews · doi:10.1016/0165-0173(82)90010-8 · Cited by 1,140 · cited 2×
“Should be taken into account is that these two nuclei receive important noradrenergic inputs from the NTS [28,32], whose activation in morphine-withdrawn rats is not attenuated by the OX1R antagonist.”
BackgroundDistribution of orexin receptor mRNA in the rat brain
Trivedi, P., Yu, H., MacNeil, D. J., Van der Ploeg, L. H. T., & Guan, X.-M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01266-6 · Cited by 978
Arousal and reward: a dichotomy in orexin function
Harris, G. C., & Aston-Jones, G. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.08.002 · Cited by 565 · cited 1×
“Heterogeneity in orexin neurons has been described in previous animal studies [17]: orexinergic neurons located in the DMH and PFA have been suggested to control arousal and modulate stress responses, whereas neurons in the LLH project to areas related to positive reinforcing effects of drugs.”
ResultNoradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion
Delfs, J. M., Zhu, Y., Druhan, J. P., & Aston-Jones, G. (2000) · Nature · doi:10.1038/35000212 · Cited by 462 · cited 2×
“The NTS-A2 cell group, the main noradrenergic cell group innervating the brain stress system [8], is also activated after naloxone-precipitated opiate withdrawal.”
BackgroundThe orexin system regulates alcohol-seeking in rats
Lawrence, A. J., Cowen, M. S., Yang, H., Chen, F., & Oldfield, B. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706789 · Cited by 392 · cited 1×
“dose of SB334867 is consistent with other recent studies [15,41].”
ResultInvolvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal
Georgescu, D., Zachariou, V., Barrot, M., Mieda, M., Willie, J. T., Eisch, A. J., Yanagisawa, M., Nestler, E. J., & DiLeone, R. J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03106.2003 · Cited by 373 · cited 13×
“Chronic morphine treatment and naloxone-precipitated morphine withdrawal do not modify the number of OXA neurons in the LH To evaluate if chronic morphine and naloxone-precipitated morphine withdrawal differentially affects the number of OXA neurons in the LH, the cell counts of OXA immunoreactive profiles were taken…”
BackgroundResultInfluentialBaldo, B. A., Daniel, R. A., Berridge, C. W., & Kelley, A. E. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10783 · Cited by 346 · cited 1×
“. Orexinergic neurons arising in the DMH and PFA project to brainstem nuclei and involved in control of arousal and modulation of stress responses”
BackgroundA selective orexin-1 receptor antagonist reduces food consumption in male and female rats
Haynes, A. C., Jackson, B., Chapman, H., Tadayyon, M., Johns, A., Porter, R. A., & Arch, J. R. S. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00199-3 · Cited by 338 · cited 1×
“with the selective OX1R antagonist SB334867 [40], at the dose of 20 mg/kg i.”
BackgroundStinus, L., Le Moal, M., & Koob, G. F. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90106-e · Cited by 317 · cited 1×
“NAc shell has been related to the expression of morphine withdrawal somatic symptoms [15], together with the CeA and BNST [24,25].”
BackgroundReduction of Morphine Abstinence in Mice with a Mutation in the Gene Encoding CREB
Maldonado, R., Blendy, J. A., Tzavara, E., Gass, P., Roques, B. P., Hanoune, J., & Schütz, G. (1996) · Science · doi:10.1126/science.273.5275.657 · Cited by 292 · cited 1×
“a relative weight as previously reported [38]: jumping x 0,8; wet dog shakes x 1; paw tremor x 0,35; sniffing x 0,5; writhing x 0,5;”
BackgroundCentrally administered orexin/hypocretin activates HPA axis in rats
Kuru, M., Ueta, Y., Serino, R., Nakazato, M., Yamamoto, Y., Shibuya, I., & Yamashita, H. (2000) · NeuroReport · doi:10.1097/00001756-200006260-00034 · Cited by 286 · cited 6×
“) OXA increases plasma levels of glucocorticoids and ACTH [13].”
BackgroundInfluentialASTON‐JONES, G., DELFS, J. M., DRUHAN, J., & ZHU, Y. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09284.x · Cited by 250 · cited 3×
“In addition, BNST receive noradrenergic inputs originating in the NTS [25].”
BackgroundOlive, M. F., Koenig, H. N., Nannini, M. A., & Hodge, C. W. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00748-1 · Cited by 237
Forray, M. I., & Gysling, K. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.07.011 · Cited by 191
Frenois, F., Cador, M., Caillé, S., Stinus, L., & Le Moine, C. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02187.x · Cited by 179 · cited 1×
“after acute injection of opioid antagonists [34].”
Sakamoto, F., Yamada, S., & Ueta, Y. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2003.12.014 · Cited by 172 · cited 1×
“It has been previously reported that OXA has an excitatory action on the CeA [29], and that this activation occurs in CRFcontaining neurons [30].”
BackgroundSharf, R., Sarhan, M., & Dileone, R. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.006 · Cited by 155 · cited 16×
“Chronic morphine treatment and naloxone-precipitated morphine withdrawal do not modify the number of OXA neurons in the LH To evaluate if chronic morphine and naloxone-precipitated morphine withdrawal differentially affects the number of OXA neurons in the LH, the cell counts of OXA immunoreactive profiles were taken…”
BackgroundMethodResultInfluentialSamson, W. K., Taylor, M. M., Follwell, M. J., & Ferguson, A. V. (2002) · Regulatory Peptides · doi:10.1016/s0167-0115(01)00353-6 · Cited by 146 · cited 1×
“It has been reported that OXA activates PVN neurons [12] and that intracerebroventricular (i.”
BackgroundGold, L. H., Stinus, L., Inturrisi, C. E., & Koob, G. F. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90755-2 · Cited by 136 · cited 1×
“. Dependence on morphine (as measured by withdrawal response) is achieved 24 h after implantation of pellets and remained constant for 15 days”
MethodGuitart, X., & Nestler, E. (1989) · The Journal of Neuroscience · doi:10.1523/jneurosci.09-12-04371.1989 · Cited by 122
The brain hypocretins and their receptors: mediators of allostatic arousal
Carter, M. E., Borg, J. S., & de Lecea, L. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.12.018 · Cited by 107 · cited 1×
“On the other hand, noradrenaline (NA), dopamine (DA), serotonin, neuropeptide Y, and leptin inhibit orexinergic cells [6].”
BackgroundExcitatory action of hypocretin/orexin on neurons of the central medial amygdala
Bisetti, A., Cvetkovic, V., Serafin, M., Bayer, L., Machard, D., Jones, B. E., & Mühlethaler, M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.07.018 · Cited by 98 · cited 1×
“It has been previously reported that OXA has an excitatory action on the CeA [29], and that this activation occurs in CRFcontaining neurons [30].”
BackgroundLu, L., Liu, D., Ceng, X., & Ma, L. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.01310.x · Cited by 89
Harris, G. C. M., & Aston‐Jones, G. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.10.012 · Cited by 88 · cited 1×
“Present data show that BNST CRF neurons were not activated after naloxone administration to morphine dependent rats, which is in agreement with previous data showing no increase in c-Fos expression in BNST CRF neurons in morphine-withdrawn rats [31].”
ResultChang, H., Saito, T., Ohiwa, N., Tateoka, M., Deocaris, C. C., Fujikawa, T., & Soya, H. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.11.009 · Cited by 75 · cited 4×
“Given that the PVN receives orexinergic inputs arising from both the PFA and the LLH subdivisions of the LH [18], our data might suggest the involvement of OXA neurons arising not only from the DMH and PFA, but also from the LLH, in the activation of the brain stress system during opiate withdrawal.”
BackgroundInfluentialLaorden, M. L., Fuertes, G., Cuello, A. M. G., & Milanés, M. V. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39271-7 · Cited by 72
Self-citationLaorden, M. L., Fuertes, G., Cuello, A. M. G., et al. (2000) · PubMed · Cited by 71
Self-citationActivation of stress‐related hypothalamic neuropeptide gene expression during morphine withdrawal
Núñez, C., Földes, A., Laorden, M. L., Milanés, M. V., & Kovács, K. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04421.x · Cited by 68
Self-citationHoushyar, H., Manalo, S., & Dallman, M. F. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1641-04.2004 · Cited by 68 · cited 1×
“morphine treatment induces a decrease in body weight gain due to lower caloric intake [20,39].”
BackgroundLi, Y., Wang, H., Qi, K., Chen, X., Li, S., Sui, N., & Kirouac, G. J. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.10.006 · Cited by 65 · cited 1×
“Furthermore, present data reveal a critical involvement of the orexinergic system in the physical symptoms of opiate abstinence syndrome, supporting a therapeutic potential of OX1R antagonists in addictive disorders, as has been proposed [15,33].”
BackgroundZhou, Y., Proudnikov, D., Yuferov, V., & Kreek, M. J. (2010) · Brain Research · doi:10.1016/j.brainres.2009.11.015 · Cited by 58 · cited 1×
“Recent investigations revealed participation of the orexinergic system in brain stress system [11].”
BackgroundNúñez, C., Földes, A., Pérez-Flores, D., García-Borrón, J. C., Laorden, M. L., Kovács, K., & Milanés, M. V. (2009) · Endocrinology · doi:10.1210/en.2008-1732 · Cited by 56
Self-citationAzizi, H., Mirnajafi‐Zadeh, J., Rohampour, K., & Semnanian, S. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.07.050 · Cited by 55
Interactions of orexins/hypocretins with adrenocortical functions
Kagerer, S. M., & Jöhren, O. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.02034.x · Cited by 40 · cited 1×
“Furthermore, it is well established that orexins exert an influence on the regulation of the hypothalamus-pituitary-adrenal axis, acting both on its central peripheral branch [27].”
BackgroundZaragoza, J. N., Núñez, C., Ruiz‐Medina, J., Laorden, M. L., Valverde, O., & Milanés, M. V. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01090.x · Cited by 35
Self-citationKatayama, S., Shigemi, K., Cline, M. A., & Furuse, M. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.08.043 · Cited by 13 · cited 1×
“However, conflicting findings have been published concerning the activity of the orexinergic system on the HPA axis [18,26].”
Background
Cited by
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
Orexin/hypocretin role in reward: implications for opioid and other addictions
Baimel, C., Bartlett, S. E., Chiou, L., Lawrence, A. J., Muschamp, J. W., Patkar, O., Tung, L., & Borgland, S. L. (2015) · British Journal of Pharmacology · doi:10.1111/bph.12639 · Cited by 179
“Withdrawal-induced Fos activation in hypothalamic orexin neurons Morphine withdrawal induced by naloxone administration increases Fos activation of LH orexin neurons in mice (Georgescu et al., 2003) and rats (Laorden et al., 2012).”
BackgroundInfluentialAllostatic mechanisms of opioid tolerance beyond desensitization and downregulation
Cahill, C. M., Walwyn, W., Taylor, A. M. W., Pradhan, A. A. A., & Evans, C. J. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.08.002 · Cited by 122
“Finally, orexin neurons from the lateral region of the hypothalamus that project to the NAc, implicated in the brain stress system, block both the somatic physical symptoms and increased corticosterone levels associated with opioid withdrawal [104].”
The intersection of stress and reward: BNST modulation of aversive and appetitive states
Ch'ng, S., Fu, J., Brown, R. M., McDougall, S. J., & Lawrence, A. J. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.01.005 · Cited by 112
“Systemic delivery of SB-334867 attenuated activation of the BNST during morphine withdrawal, pointing to a potential role for orexin input to the BNST in drug-related withdrawal (Laorden et al., 2012).”
Role of the Orexin/Hypocretin System in Stress-Related Psychiatric Disorders
James, M. H., Campbell, E. J., & Dayas, C. V. (2017) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_56 · Cited by 110
Metadata
- Authors
- Laorden, M. L., Ferenczi, S., Pintér-Kübler, B., González-Martín, L. L., Lasheras, M. C., Kovács, K. J., Milanés, M. V., & Núñez, C.
- Affiliations
- Instituto Murciano de Investigación Biosanitaria (ES)
- HUN-REN Institute of Experimental Medicine (HU)
- Corresponding author
- Milanés, M. Victoria
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-05-09
- Volume
- 7
- Issue
- 5
- Pages
- e36871
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3348891
- OpenAlex
- W1981813055
- Cited by
- 55
- References
- 43
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 7 · 2022: 2 · 2021: 3 · 2020: 3 · 2019: 4 · 2018: 2 · 2017: 5 · 2016: 4 · 2015: 1 · 2014: 10 · 2013: 8 · 2012: 1
- FWCI
- 2.64
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Hungarian Scientific Research Fund
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- orexin-A, morphine withdrawal, lateral hypothalamus, OX1 receptor, SB-334867, hypothalamic-pituitary-adrenal axis, extended amygdala, opioid use disorder, naloxone-precipitated withdrawal, Fos expression, nucleus accumbens shell, bed nucleus of the stria terminalis, central amygdala, paraventricular nucleus
- MeSH terms
- Orexins, Amygdala, Animals, Hypothalamo-Hypophyseal System, Male, Morphine, Morphine Dependence, Narcotics, Neurons, Neuropeptides, Paraventricular Hypothalamic Nucleus, Pituitary-Adrenal System, Substance Withdrawal Syndrome, Rats, Wistar, Receptors, Neuropeptide, Receptors, G-Protein-Coupled, Intracellular Signaling Peptides and Proteins, Rats, Orexin Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.